Acorah Software Products - Accounts Production 16.5.460 false true 31 March 2024 1 April 2023 false 1 April 2024 31 March 2025 31 March 2025 10799442 Dr RK Singh Mrs EM Singh iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 10799442 2024-03-31 10799442 2025-03-31 10799442 2024-04-01 2025-03-31 10799442 frs-core:CurrentFinancialInstruments 2025-03-31 10799442 frs-core:RevaluationReserve 2024-04-01 2025-03-31 10799442 frs-core:RevaluationReserve 2024-03-31 10799442 frs-core:RevaluationReserve 2025-03-31 10799442 frs-core:ShareCapital 2025-03-31 10799442 frs-core:RetainedEarningsAccumulatedLosses 2025-03-31 10799442 frs-bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 10799442 frs-bus:FilletedAccounts 2024-04-01 2025-03-31 10799442 frs-bus:SmallEntities 2024-04-01 2025-03-31 10799442 frs-bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 10799442 frs-bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 10799442 frs-core:UnlistedNon-exchangeTraded 2025-03-31 10799442 frs-core:UnlistedNon-exchangeTraded 2024-03-31 10799442 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2024-03-31 10799442 frs-core:AdditionsToInvestments frs-core:UnlistedNon-exchangeTraded 2025-03-31 10799442 frs-core:RevaluationsIncreaseDecreaseInInvestments frs-core:UnlistedNon-exchangeTraded 2025-03-31 10799442 frs-core:CostValuation frs-core:UnlistedNon-exchangeTraded 2025-03-31 10799442 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2024-03-31 10799442 frs-core:ProvisionsForImpairmentInvestments frs-core:UnlistedNon-exchangeTraded 2025-03-31 10799442 frs-bus:Director1 2024-04-01 2025-03-31 10799442 frs-bus:Director2 2024-04-01 2025-03-31 10799442 frs-countries:EnglandWales 2024-04-01 2025-03-31 10799442 2023-03-31 10799442 2024-03-31 10799442 2023-04-01 2024-03-31 10799442 frs-core:CurrentFinancialInstruments 2024-03-31 10799442 frs-core:RevaluationReserve 2024-03-31 10799442 frs-core:ShareCapital 2024-03-31 10799442 frs-core:RetainedEarningsAccumulatedLosses 2024-03-31
Registered number: 10799442
Torwood Medical Ltd
Unaudited Financial Statements
For The Year Ended 31 March 2025
Contents
Page
Balance Sheet 1—2
Notes to the Financial Statements 3—4
Page 1
Balance Sheet
Registered number: 10799442
2025 2024
Notes £ £ £ £
FIXED ASSETS
Investments 4 244,119 166,791
244,119 166,791
CURRENT ASSETS
Debtors 5 19,140 72,065
Cash at bank and in hand 121,860 63,329
141,000 135,394
Creditors: Amounts Falling Due Within One Year 6 (33,921 ) (40,676 )
NET CURRENT ASSETS (LIABILITIES) 107,079 94,718
TOTAL ASSETS LESS CURRENT LIABILITIES 351,198 261,509
NET ASSETS 351,198 261,509
CAPITAL AND RESERVES
Called up share capital 7 100 100
Revaluation reserve 8 19,514 16,146
Profit and Loss Account 331,584 245,263
SHAREHOLDERS' FUNDS 351,198 261,509
Page 1
Page 2
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board
Dr RK Singh
Director
21/08/2025
The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Notes to the Financial Statements
1. General Information
Torwood Medical Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 10799442 . The registered office is 36 Endcliffe Grove Avenue, Sheffield, S10 3EJ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.

2.3. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other year and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.


3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
4. Investments
Unlisted
£
Cost or Valuation
As at 1 April 2024 166,791
Additions 73,960
Revaluations 3,368
As at 31 March 2025 244,119
Provision
As at 1 April 2024 -
As at 31 March 2025 -
Net Book Value
As at 31 March 2025 244,119
As at 1 April 2024 166,791
5. Debtors
2025 2024
£ £
Due within one year
Trade debtors 19,140 72,065
Page 3
Page 4
6. Creditors: Amounts Falling Due Within One Year
2025 2024
£ £
Corporation tax 25,898 15,080
Accruals and deferred income 1,895 7,286
Directors' loan accounts 6,128 18,310
33,921 40,676
7. Share Capital
2025 2024
£ £
Allotted, Called up and fully paid 100 100
8. Reserves
Revaluation Reserve
£
As at 1 April 2024 16,146
Transfer to profit and loss 3,368
As at 31 March 2025 19,514
Page 4